ALKEM — Alkem Laboratories Share News
0.000.00%
Last trade - 00:00- IN₹603.80bn
- IN₹588.95bn
- IN₹147.12bn
Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India
Brief: Alkem Labs Receives 30 Acre Land Allotment In Ujjain For Greenfield Facility
Brief: Alkem Labs Says US FDA Issues Form 483 With 6 Procedural Observations
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
India's Alkem Laboratories falls after quarterly profit miss
India's Alkem Laboratories unit to buy up to 55% stake in Occlutech Holding for $118 million (updated)
Brief: Alkem Labs Says Alkem Medtech To Buy 51%-55% Of Occlutech
India's Alkem Laboratories unit to buy up to 55% stake in Occlutech Holding for 99.4 million euros
Brief: Alkem Labs Says Alkem Medtech Intends To Buy Up To 55% Stake In Occlutech For EUR 99.4 Million
Brief: Alkem Laboratories Q3 Consol Net Profit 6.36 Billion Rupees
Brief: Alkem Labs Gets Tax Demand And Penalty For 23.5 Million Rupees Each
Brief: Alkem Labs Gets Tax Demand Of 38.3 Million Rupees, Tax Penalty Of 3.8 Million Rupees
Brief: Alkem Labs Launches Renocia Cyclical Therapy Kit
Brief: Alkem Labs Gets Tax Penalty Of 10.9 Million Rupees
Brief: Alkem Labs Buys Shares In Enzene Biosciences For 3 Billion Rupees
Explainer: What will change with the US reclassification of marijuana?
Explainer: What will change if the US reclassifies marijuana?
Brief: Alkem Labs Sept-Quarter Consol Net Profit 7.65 Billion Rupees